208 related articles for article (PubMed ID: 25437438)
1. The Rapalogue, CCI-779, improves salivary gland function following radiation.
Morgan-Bathke M; Harris ZI; Arnett DG; Klein RR; Burd R; Ann DK; Limesand KH
PLoS One; 2014; 9(12):e113183. PubMed ID: 25437438
[TBL] [Abstract][Full Text] [Related]
2. Deletion of ATG5 shows a role of autophagy in salivary homeostatic control.
Morgan-Bathke M; Lin HH; Chibly AM; Zhang W; Sun X; Chen CH; Flodby P; Borok Z; Wu R; Arnett D; Klein RR; Ann DK; Limesand KH
J Dent Res; 2013 Oct; 92(10):911-7. PubMed ID: 23884556
[TBL] [Abstract][Full Text] [Related]
3. Autophagy correlates with maintenance of salivary gland function following radiation.
Morgan-Bathke M; Hill GA; Harris ZI; Lin HH; Chibly AM; Klein RR; Burd R; Ann DK; Limesand KH
Sci Rep; 2014 Jun; 4():5206. PubMed ID: 24903000
[TBL] [Abstract][Full Text] [Related]
4. Restoration of radiation therapy-induced salivary gland dysfunction in mice by post therapy IGF-1 administration.
Grundmann O; Fillinger JL; Victory KR; Burd R; Limesand KH
BMC Cancer; 2010 Aug; 10():417. PubMed ID: 20698985
[TBL] [Abstract][Full Text] [Related]
5. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
Rosenthal DI; Chambers MS; Weber RS; Eisbruch A
Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological activation of the EDA/EDAR signaling pathway restores salivary gland function following radiation-induced damage.
Hill G; Headon D; Harris ZI; Huttner K; Limesand KH
PLoS One; 2014; 9(11):e112840. PubMed ID: 25409170
[TBL] [Abstract][Full Text] [Related]
7. Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results.
Eisbruch A; Ship JA; Martel MK; Ten Haken RK; Marsh LH; Wolf GT; Esclamado RM; Bradford CR; Terrell JE; Gebarski SS; Lichter AS
Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):469-80. PubMed ID: 8892473
[TBL] [Abstract][Full Text] [Related]
8. Protection against irradiation-induced damage to salivary glands by adrenergic agonist administration.
Nagler RM; Laufer D
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):477-81. PubMed ID: 9457838
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.
Chao KS; Deasy JO; Markman J; Haynie J; Perez CA; Purdy JA; Low DA
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):907-16. PubMed ID: 11240231
[TBL] [Abstract][Full Text] [Related]
10. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer.
Eisbruch A; Kim HM; Terrell JE; Marsh LH; Dawson LA; Ship JA
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):695-704. PubMed ID: 11395238
[TBL] [Abstract][Full Text] [Related]
11. The effects of heparan sulphate mimetic RGTA-OTR4120 on irradiated murine salivary glands.
Spiegelberg L; Djasim UM; van Neck JW; Wolvius EB; van der Wal KG
J Oral Pathol Med; 2012 Jul; 41(6):477-83. PubMed ID: 22233383
[TBL] [Abstract][Full Text] [Related]
12. Prevention of irradiation-induced salivary hypofunction by rapamycin in swine parotid glands.
Zhu Z; Pang B; Iglesias-Bartolome R; Wu X; Hu L; Zhang C; Wang J; Gutkind JS; Wang S
Oncotarget; 2016 Apr; 7(15):20271-81. PubMed ID: 26958808
[TBL] [Abstract][Full Text] [Related]
13. A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with intensity-modulated radiotherapy.
Strigari L; Benassi M; Arcangeli G; Bruzzaniti V; Giovinazzo G; Marucci L
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):269-76. PubMed ID: 20100642
[TBL] [Abstract][Full Text] [Related]
14. PKCζ and JNK signaling regulate radiation-induced compensatory proliferation in parotid salivary glands.
Wong WY; Allie S; Limesand KH
PLoS One; 2019; 14(7):e0219572. PubMed ID: 31287841
[TBL] [Abstract][Full Text] [Related]
15. Scintigraphic assessment of salivary function after intensity-modulated radiotherapy for head and neck cancer: correlations with parotid dose and quality of life.
Chen WC; Lai CH; Lee TF; Hung CH; Liu KC; Tsai MF; Wang WH; Chen H; Fang FM; Chen MF
Oral Oncol; 2013 Jan; 49(1):42-8. PubMed ID: 22854066
[TBL] [Abstract][Full Text] [Related]
16. Modification of the submandibular gland transfer procedure.
Marzouki HZ; Elkhalidy Y; Jha N; Scrimger R; Debenham BJ; Harris JR; O'Connell DA; Seikaly H
Laryngoscope; 2016 Nov; 126(11):2492-2496. PubMed ID: 27171786
[TBL] [Abstract][Full Text] [Related]
17. Reducing Xerostomia by Comprehensive Protection of Salivary Glands in Intensity-Modulated Radiation Therapy with Helical Tomotherapy Technique for Head-and-Neck Cancer Patients: A Prospective Observational Study.
Teng F; Fan W; Luo Y; Ju Z; Gong H; Ge R; Tong F; Zhang X; Ma L
Biomed Res Int; 2019; 2019():2401743. PubMed ID: 31380414
[TBL] [Abstract][Full Text] [Related]
18. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009
[TBL] [Abstract][Full Text] [Related]
19. [Normal tissue tolerance to external beam radiation therapy: salivary glands].
Ortholan C; Benezery K; Bensadoun RJ
Cancer Radiother; 2010 Jul; 14(4-5):290-4. PubMed ID: 20609609
[TBL] [Abstract][Full Text] [Related]
20. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.
Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1479-87. PubMed ID: 20934262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
